Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$212.76 +0.79 (+0.37%)
As of: Oct 22, 2026 · 12:32 PM EDT

Jazz Pharmaceuticals (JAZZ) Short-Term Debt repayments (2015 - 2017)

Updated

Jazz Pharmaceuticals (JAZZ) posted Short-Term Debt repayments of $500 million for FY2020.

Analysis

Jazz Pharmaceuticals (JAZZ) Short-Term Debt repayments (2015 - 2017) Analysis & Trends

Since FY2014, Jazz Pharmaceuticals has reported Short-Term Debt repayments for 5 years.

  • Annual Short-Term Debt repayments shows a five-year compound annual growth rate of 25.6% (FY2015 to FY2020).
  • The FY2020 figure stands as the highest annual Short-Term Debt repayments since FY2017.
  • Business Quant data shows JAZZ's Short-Term Debt repayments at $850 million in FY2017 (+466.7%) and $150 million in FY2016 (-6.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,174.91 Bn 1,143.49 Bn 19.71 Bn -
2 Johnson & Johnson 644.40 Bn 562.93 Bn 17.26 Bn 6.45 Bn
3 AbbVie 503.86 Bn 476.97 Bn 12.70 Bn -
4 Merck 379.74 Bn 334.12 Bn 12.21 Bn -
5 Novartis Ag 303.49 Bn 267.48 Bn 11.24 Bn -
6 Astrazeneca 269.36 Bn 243.04 Bn 12.86 Bn -
7 Amgen 243.43 Bn 198.83 Bn 7.24 Bn -
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn -
9 Pfizer 172.94 Bn 119.58 Bn 10.94 Bn -
10 Jazz Pharmaceuticals 13.46 Bn 7.28 Bn 1.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 500.00 Mn
Jun 30, 2017 200.00 Mn
Mar 31, 2017 150.00 Mn
Dec 31, 2016 150.00 Mn
Dec 31, 2015 80.00 Mn
API Access

Jazz Pharmaceuticals Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=JAZZ&period=max&api_key=YOUR_API_KEY